Your data on MRCVSonline
The nature of the services provided by Vision Media means that we might obtain certain information about you.
Please read our Data Protection and Privacy Policy for details.

In addition, (with your consent) some parts of our website may store a 'cookie' in your browser for the purposes of
functionality or performance monitoring.
Click here to manage your settings.
If you would like to forward this story on to a friend, simply fill in the form below and click send.

Your friend's email:
Your email:
Your name:
 
 
Send Cancel

Is there a better way of doing this?
Dr Mark Holmes.
"Evidence-based medicine is simply a change in thinking and should not be used in a dogmatic fashion."

"Evidence-based medicine is simply a change in thinking and should be part of the overall approach to our patients," said Dr Mark Holmes speaking on the subject during a session on 'Professionalism' at the BVNA Congress.

He explained that good clinician bases the art of veterinary medicine on the evidence of science. And science is a methodical and systematic process to search for truth through hypothetico-deductive reasoning involving scepticism and a recognition of uncertainty, in an objective way.

Dr Holmes said he wanted to see a shift from 'eminence-based' medicine to evidence-based medicine that is underpinned by scientific tests. It is important to use tests to differentiate between belief and proven fact. Our senses can mislead our perception and interpretation and it is only through the use of statistics that randomness and subjectiveness can be eliminated.

"To buy one lottery ticket purchases hope; to buy more than one demonstrates the triumph of hope over expectation," he said.

There are two key factors when assessing statistics – How likely is it that my result is a 'lottery win'? and How representative is the result? When using statistics we acknowledge our doubt; although unless we are completely without imagination, we can always think of an alternative reason for an observation.

"Our patients may get better in spite of our treatments rather than because of them," said Dr Holmes. "Whenever we are asked about why we have made a particular clinical decision, we should always be able to explain and justify our action on the basis of our scientific training and experience in practice."

The two key factors in setting up a clinical trial are randomising of patients and blinding of the therapy; and the two key factors in assessing the results are the 'number needed to treat' and 'confidence intervals' provided by subsequent statistical analysis.  

"Be sceptical, look for the evidence, and use this approach for lifetime learning," said Dr Holmes. "Is there a better way of doing this? The application of science to patient care may not be the best way to cure our patients' but I believe that it is the least worst," he concluded.

Become a member or log in to add this story to your CPD history

Defra shares new Sanitary and Phytosanitary guidance

News Story 1
 Defra has published guidance for the vet sector ahead of a proposed UK-EU Sanitary and Phytosanitary agreement.

The agreement, which will change the movement and trade of animals and related products, could see reductions in checks, paperwork and certification. As well as describing regulatory developments, the advice highlights the importance of animal ID, registration and traceability in disease control and other compliance arrangements.

The guidance can be found here. More detail is expected as negotiations progress. 

Click here for more...
News Shorts
Lords Committee opens Pet Parasite Medication inquiry

The House of Lords Environment and Climate Change Committee will launch its inquiry into Pet Parasite Medication (PPM) on Wednesday (3 June).

Focusing on treatments containing fipronil and imidacloprid, the inquiry will seek to understand distribution pathways and the impacts of PPM use and non-use on biodiversity and human health. It will also cover current regulation, monitoring, and the potential implications for pets and their owners.

The committee will hear evidence from environmental non-governmental organisations and research institutes. The public can follow the proceedings live on Parliament TV or in person in the Palace of Westminster.